This small-cap stock has given mind-boggling returns to its investors, generating multi-bagger returns of over 2100 percent in a year, and 18000 percent returns in 5 years.
Remedium Lifecare Limited is involved in trading and selling various Advanced Pharmaceutical Intermediates (APIs) and other pharma products. To learn more about the company, visit the Remedium Lifecare website.
Market Cap | ₹1,107 Cr. |
Current Price | ₹549 |
Intrinsic Value | ₹107 |
High / Low | ₹898 / ₹24.9 |
EPS | ₹4.22 |
Stock P/E | 130 |
Industry PE | 52.8 |
ROCE | 103% |
ROE | 71% |
Face Value | ₹5 |
PEG Ratio | 0.51 |
Promoters Holding | 1.11% |
Pledged percentage | 0% |
Debt | ₹1.18 Cr. |
Debt to equity | 0.05 |
Cash Equivalents | ₹0.41 Cr. |
Sales growth | 108% |
Inventory | ₹39.3 Cr. |
Current liabilities | ₹1,884 Cr. |
Current assets | ₹1,906 Cr. |
NCAVPS | ₹11.5 |
Remedium Lifecare Limited Year-After-Year Performance
Year | Open | Close | Gain/ Fall |
2018 | ₹2.25 | ₹2.95 | 31.11% |
2019 | ₹2.99 | ₹3.98 | 33.11% |
2020 | ₹3.98 | ₹8.44 | 112.06% |
2021 | ₹8.47 | ₹24.82 | 193.03% |
2022 | ₹24.80 | ₹25.13 | 1.33% |
2023 | ₹24.91 | ₹501.40 | 1912.85% |
2024 | ₹498.95 | ₹549.00 | 10.03% |
Remedium Lifecare has performed very well year after year. It showed a growth of over 112% in 2020, and 193% in 2021, and became a multibagger stock in 2023. In 2023 alone, it showed a growth of 1912% and multiplied its investors’ money 20 times.
Remedium Lifecare Limited Compound Performance
Period | Growth | Returns on ₹10k | CAGR |
1 Year | 2096% | ₹2.1 Lakh | 2096% |
2 Years | 2107% | ₹2.2 Lakh | 369% |
3 Years | 5407% | ₹5.5 Lakh | 280% |
4 Years | 15066% | ₹15 Lakh | 250% |
5 Years | 18261% | ₹18 Lakh | 183% |
MAX | 24300% | ₹24 Lakh | 165% |
- This stock has increased by 2096% in one year and by 2107% in the last 2 years.
- The money of investors who had invested in it three years ago has increased 55 times.
- For those who had invested Rs 10,000 in this stock four years ago, today the value of those Rs 10,000 shares has become Rs 15 lakh.
- The stock has grown at a CAGR of 183% in the last five years.
Remedium Lifecare Profit & Loss
Figures in Rs. Crores
Profit & Loss | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
Sales | 0 | 3 | 90 | 505 | 510 | 1,051 |
Operating Profit | 0 | 0 | 1 | 2 | 8 | 12 |
OPM % | -44% | 14% | 1% | 0% | 2% | 1% |
Net Profit | 0 | 0 | 0 | 1 | 5 | 9 |
EPS in Rs | 0 | 0.14 | 0.24 | 0.53 | 2.69 | 4.22 |
The company’s sales were quite good from the beginning but the company was not profitable. But in the last few years, it has also become profitable, which is expected to continue in the future also, that is why investors have bought heavily.
The company is almost debt-free and is expected to perform well in the coming quarter results. The company has recorded a good profit growth of 252% CAGR over the last 5 years, and an ROE of 44.6% over the last 3 years.
Remedium Lifecare Shareholding Pattern
Shareholding Pattern | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
Promoters | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% |
FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.04% | 0.08% |
Public | 98.89% | 98.88% | 98.88% | 98.88% | 98.84% | 98.81% |
No. of Shareholders | 622 | 604 | 622 | 705 | 1,730 | 3,988 |
Promoters have continuously reduced their stake. Three years ago, promoter holding was 43.57%, which has now come down to 1.11% and public holding has increased to 98.81%.
Disclaimer: This article is written for informational purposes only, do not consider it any investment advice.